Journal
CELL STEM CELL
Volume 18, Issue 5, Pages 668-681Publisher
CELL PRESS
DOI: 10.1016/j.stem.2016.03.002
Keywords
-
Categories
Funding
- Leukemia & Lymphoma Society Fellow Award
- U.S. NIH [RO1DK043889, R37HL052725, P01HL048546]
Ask authors/readers for more resources
Fanconi anemia (FA) is an inherited DNA repair disorder characterized by progressive bone marrow failure (BMF) from hematopoietic stem and progenitor cell (HSPC) attrition. A greater understanding of the pathogenesis of BMF could improve the therapeutic options for FA patients. Using a genome-wide shRNA screen in human FA fibroblasts, we identify transforming growth factor-beta (TGF-beta) pathway-mediated growth suppression as a cause of BMF in FA. Blocking the TGF-beta pathway improves the survival of FA cells and rescues the proliferative and functional defects of HSPCs derived fromFA mice and FA patients. Inhibition of TGF-beta signaling in FA HSPCs results in elevated homologous recombination (HR) repair with a concomitant decrease in non-homologous end-joining (NHEJ), accounting for the improvement in cellular growth. Together, our results suggest that elevated TGF-beta signaling contributes to BMF in FA by impairing HSPC function and may be a potential therapeutic target for the treatment of FA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available